(Q33888820)

29 July 2017

1 reference

title

Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues (English)

1 reference

29 July 2017

liver transplantation

1 reference

1 reference

1 reference

Samuel D

1

1 reference

PubMed ID

10760038

29 July 2017

Feray C

series ordinal

2

1 reference

29 July 2017

1 March 2000

1 reference

Journal of Viral Hepatitis

29 July 2017

1 reference

29 July 2017

7

1 reference

29 July 2017

2

1 reference

29 July 2017

87-92

1 reference

Reinfection of liver graft by hepatitis C virus after liver transplantation

29 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Cholestatic hepatitis C in liver allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

A longitudinal analysis of hepatitis C virus replication following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Histological and clinical outcome after liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

The influence of hepatitis C virus genotypes on the outcome of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Long-term outcome of hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Dynamic analysis of hepatitis C virus polymorphism in patients with orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Hepatitis C infection in patients undergoing liver retransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Effect of immune globulin on the prevention of experimental hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00202.X

10.1046/J.1365-2893.2000.00202.X

21 January 2018

Identifiers

DOI

1 reference

release_cjsobn2su5dshh56efujs23jqu

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cjsobn2su5dshh56efujs23jqu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10760038

1 reference

PubMed ID

10760038